MedTrace Logo

Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions

NCT05625308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-12-22

No results posted yet for this study

Summary

To test the efficacy of a newly-commercialized formula, 40 HPV-positive women displaying chronic cervicitis, mild dysplasia or moderate dysplasia. Women in the study group took one tablet per day containing 200 mg of EGCG, 400 mcg of Folic Acid, 1 mg of Vitamin B12 and 50 mg of Hyaluronic Acid for twelve weeks. Women in the control group received no treatment.

Conditions

  • Papilloma
  • Cervix Lesion

Interventions

DIETARY_SUPPLEMENT

Epigallocatechin gallate, Folic acid, Vitamin B12, and Hyaluronic Acid

One tablet per day containing 200 mg of EGCG, 400 mcg of Folic Acid, 1 mg of Vitamin B12 and 50 mg of Hyaluronic Acid.

Sponsors & Collaborators

  • Lo.Li.Pharma s.r.l

    lead INDUSTRY

Principal Investigators

  • Cesare Aragona, MD · Clinica Alma Res

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-11-09
Completion
2022-12-02

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05625308 on ClinicalTrials.gov